4
Changes in Ownership
Anixa Biosciences Inc Filed Acc 0001513162-17-000104
President and CEO acquired 5,995 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BERMAN ROBERT ANDREW · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-04-03 | Option exercise : show line 1 in the form | +5,995 | $2.38 | $14,268 | 51,553 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-04-03 | Option exercise : show line 2 in the form Subscription Right | −5,995 | 0 | D |
Loading xslF345X03/primary_doc.xml…